A case of IgE-mediated hypersensitivity to ceftriaxone

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 5, 1999, Pages 1113-1114

  Romano, Antonino ^a,b,e   Quaratino, Donato ^a   Venemalm, Lennart ^c   Torres, Maria Jose ^d   Venuti, Alberto ^a   Blanca, Miguel ^d  

^a CATHOLIC UNIVERSITY   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

^c Pharmacia & Upjohn AB   (Sweden)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^e Unita di Allergologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CEFOTAXIME; CEFTRIAXONE; CHLORPHENIRAMINE; IMMUNOGLOBULIN E; METHYLPREDNISOLONE;

ANAPHYLAXIS; ARTICLE; BRONCHITIS; CASE REPORT; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; HUMAN; MALE; PRIORITY JOURNAL; URTICARIA;

EID: 0032714010     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70100-4     Document Type: Article

References (5)

1. 1. Moskovitz BL. Clinical adverse effects during ceftriaxone therapy. Am J Med 1984;77:84-8.
2. 2. Feinberg JG. Allergy to antibiotics. I. Fact and conjecture on the sensitizing contaminants of penicillins and cephalosporins. Appl Immunol 1968;33:439-43.
3. 3. Newton GGF, Hamilton-Miller JMT. Cephaloridine: chemical and biochemical aspects. Postgrad Med J 1967;43(Suppl 1):10-7.
4. 4. Blanca M, Vega JM, Garcia J, Miranda A, Carmona MJ, Juarez C, et al. New aspects of allergic reactions to betalactams: crossreactions and unique specificities. Clin Exp Allergy 1994;24:405-15.
5. 13C NMR characterization of the intermediates from β-lactam ring cleavage prior to loss of the 3'-group. J Am Chem Soc 1985; 107:267-8.